In conclusion, our results have shown that lidocaine inhibited the malignant behaviors of HCC cells by downregulating circ_DYNC1H1 to reduce the expression of miR-520a-3p-mediated USP14 (Figure 9). Here, USP14 is linked to hepatocellular carcinoma.